# Ezetimibe Reverse Cholesterol Transport (RCT) Pilot Study

> **NCT00701727** · PHASE4 · COMPLETED · sponsor: **Radiant Research** · enrollment: 31 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** ezetimibe
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00701727
- **Lead sponsor:** Radiant Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2011-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00701727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00701727, "Ezetimibe Reverse Cholesterol Transport (RCT) Pilot Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00701727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*